| P50 | author | Laura P Sands | Q46618728 |
| | Kaycee M Sink | Q56993455 |
| | Huiping Xu | Q98825440 |
| P2093 | author name string | Bruce Craig | |
| | Joseph Thomas | |
| | Steven Kritchevsky | |
| P2860 | cites work | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
| | Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults | Q30050268 |
| | The validity of the minimum data set in measuring the cognitive impairment of persons admitted to nursing homes | Q30621420 |
| | Drug-induced cognitive impairment in the elderly | Q33718836 |
| | Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials | Q33912750 |
| | Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients | Q34380383 |
| | Anticholinergic effects of medication in elderly patients. | Q34390127 |
| | Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study | Q34407945 |
| | Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 |
| | Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis | Q34648742 |
| | Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials | Q34661480 |
| | Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review | Q34950386 |
| | Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis | Q35040742 |
| | Management of overactive bladder | Q35671074 |
| | Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly | Q36069271 |
| | Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients | Q36362859 |
| | Urinary incontinence in dementia - a practical approach. | Q36461660 |
| | Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology | Q36632771 |
| | The MDS Cognition Scale: a valid instrument for identifying and staging nursing home residents with dementia using the minimum data set. | Q36727105 |
| | Office management of geriatric urinary incontinence | Q36756046 |
| | Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride | Q42545567 |
| | Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system | Q42651945 |
| | Use of anticholinergic medications by older adults with dementia | Q44004627 |
| | Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors | Q44057642 |
| | Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease | Q44499334 |
| | Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia | Q44872838 |
| | Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings | Q46416659 |
| | M1 receptors play a central role in modulating AD-like pathology in transgenic mice | Q46737320 |
| | Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs | Q48238311 |
| | Cognitive and functional decline in adults aged 75 and older. | Q51951792 |
| | The hierarchy of functional loss associated with cognitive decline in older persons. | Q51963221 |
| | Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. | Q51990766 |
| | The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? | Q53265749 |
| | Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias. | Q53276294 |
| | Scaling ADLs within the MDS | Q73320336 |
| | Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients | Q73806767 |
| | Prevalence and detection of urinary incontinence among older Medicaid recipients | Q80549042 |
| | The influence of dementia on the prevalence of urinary and faecal incontinence in 85-year-old men and women | Q80577920 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 847-853 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes | |
| P478 | volume | 56 | |